Jun 10, 2021 / 12:50PM GMT
Matthew Carlisle Sykes - Goldman Sachs Group, Inc., Research Division - Research Analyst
Good morning, everyone, and welcome to the third and final day of the Goldman Sachs Healthcare Conference. I'm Matt Sykes, the Senior Life Sciences Tools & Diagnostics analyst here at Goldman. And we have the pleasure of welcoming Myriad Genetics' management team here. We have Paul Diaz, the President and Chief Executive Officer; and Bryan Riggsbee, the Chief Financial Officer.
Paul, Bryan, thanks so much for being with us today.
Paul J. Diaz - Myriad Genetics, Inc. - CEO, President & Director
Thank you, Matt.
R. Bryan Riggsbee - Myriad Genetics, Inc. - Executive VP, CFO & Treasurer
Thanks for having us.
Questions and Answers:
Matthew Carlisle Sykes - Goldman Sachs Group, Inc., Research Division - Research AnalystGreat. Maybe, Paul, I'll turn it over to you first and kind of let you set the stage and just go over a couple of the key highlights for investors
Trustpilot
